Stock Market & Financial Investment News

News Breaks December 10, 2012 09:06 EDT MACK Merrimack announces positive clinical data for agent to treat breast cancer Merrimack announced Phase I clinical trial results for MM-302, the company's agent for the treatment of advanced HER2 positive breast cancer. The findings demonstrated preliminary safety and tolerability. News For MACK From The Last 14 Days Check below for free stories on MACK the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 23, 2013 08:18 EDT MACK Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi Subscribe for More Information May 13, 2013 10:01 EDT MACK Merrimack sees FY13 cash and cash equivalents $86.7M 10:01 EDT MACK Merrimack reports Q1 EPS (29c), consensus (28c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.